Annual Total Long Term Liabilities
$1.10 M
-$28.04 M-96.24%
July 31, 2024
Summary
- As of February 7, 2025, BCTX annual total long term liabilities is $1.10 million, with the most recent change of -$28.04 million (-96.24%) on July 31, 2024.
- During the last 3 years, BCTX annual total long term liabilities has fallen by -$28.72 million (-96.32%).
- BCTX annual total long term liabilities is now -96.50% below its all-time high of $31.31 million, reached on July 31, 2022.
Performance
BCTX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$1.71 M
+$616.70 K+56.27%
October 31, 2024
Summary
- As of February 7, 2025, BCTX quarterly total long term liabilities is $1.71 million, with the most recent change of +$616.70 thousand (+56.27%) on October 31, 2024.
- Over the past year, BCTX quarterly long term liabilities has dropped by -$3.97 million (-69.84%).
- BCTX quarterly long term liabilities is now -95.07% below its all-time high of $34.77 million, reached on January 31, 2023.
Performance
BCTX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
BCTX Long Term Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -96.2% | -69.8% |
3 y3 years | -96.3% | +589.2% |
5 y5 years | +100.0% | +589.2% |
BCTX Long Term Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -96.5% | at low | -95.1% | +589.2% |
5 y | 5-year | -96.5% | -100.0% | -95.1% | -100.0% |
alltime | all time | -96.5% | -100.0% | -95.1% | -100.0% |
BriaCell Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Oct 2024 | - | $1.71 M(+56.3%) |
Jul 2024 | $1.10 M(-96.2%) | $1.10 M(-80.7%) |
Apr 2024 | - | $5.68 M(-65.8%) |
Jan 2024 | - | $16.62 M(+10.4%) |
Oct 2023 | - | $15.06 M(-48.3%) |
Jul 2023 | $29.14 M(-6.9%) | $29.14 M(-14.9%) |
Apr 2023 | - | $34.23 M(-1.6%) |
Jan 2023 | - | $34.77 M(+28.1%) |
Oct 2022 | - | $27.14 M(-13.3%) |
Jul 2022 | $31.31 M(+5.0%) | $31.31 M(>+9900.0%) |
Apr 2022 | - | $278.40 K(+12.0%) |
Jan 2022 | - | $248.50 K(-25.4%) |
Oct 2021 | - | $333.20 K(-98.9%) |
Jul 2021 | $29.82 M(>+9900.0%) | $29.82 M(+322.3%) |
Apr 2021 | - | $7.06 M(+4619.1%) |
Jan 2021 | - | $149.60 K(+3.7%) |
Oct 2020 | - | $144.30 K(-7.4%) |
Jul 2020 | $155.90 K(>+9900.0%) | $155.90 K(>+9900.0%) |
Apr 2020 | - | $0.00(0.0%) |
Jan 2020 | - | $0.00(0.0%) |
Oct 2019 | - | $0.00(0.0%) |
Jul 2019 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2019 | - | $0.00(0.0%) |
Jan 2019 | - | $0.00(0.0%) |
Oct 2018 | - | $0.00(0.0%) |
Jul 2018 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2018 | - | $0.00(0.0%) |
Jan 2018 | - | $0.00(0.0%) |
Oct 2017 | - | $0.00(0.0%) |
Jul 2017 | $0.00 | $0.00(0.0%) |
Apr 2017 | - | $0.00(0.0%) |
Jan 2017 | - | $0.00(0.0%) |
Date | Annual | Quarterly |
---|---|---|
Oct 2016 | - | $0.00(0.0%) |
Jul 2016 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2016 | - | $0.00(0.0%) |
Jan 2016 | - | $0.00(0.0%) |
Oct 2015 | - | $0.00(0.0%) |
Jul 2015 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2015 | - | $0.00(0.0%) |
Jan 2015 | - | $0.00(0.0%) |
Oct 2014 | - | $0.00(0.0%) |
Jul 2014 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2014 | - | $0.00(0.0%) |
Jan 2014 | - | $0.00(0.0%) |
Oct 2013 | - | $0.00(0.0%) |
Jul 2013 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2013 | - | $0.00(0.0%) |
Jan 2013 | - | $0.00(0.0%) |
Oct 2012 | - | $0.00(0.0%) |
Jul 2012 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2012 | - | $0.00(0.0%) |
Jan 2012 | - | $0.00(0.0%) |
Oct 2011 | - | $0.00(0.0%) |
Jul 2011 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2011 | - | $0.00(0.0%) |
Jan 2011 | - | $0.00(0.0%) |
Oct 2010 | - | $0.00(0.0%) |
Jul 2010 | $0.00(0.0%) | $0.00(0.0%) |
Apr 2010 | - | $0.00(0.0%) |
Jan 2010 | - | $0.00(0.0%) |
Oct 2009 | - | $0.00(0.0%) |
Jul 2009 | $0.00 | $0.00(0.0%) |
Apr 2009 | - | $0.00(0.0%) |
Jan 2009 | - | $0.00 |
FAQ
- What is BriaCell Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for BriaCell Therapeutics?
- What is BriaCell Therapeutics annual total long term liabilities year-on-year change?
- What is BriaCell Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for BriaCell Therapeutics?
- What is BriaCell Therapeutics quarterly long term liabilities year-on-year change?
What is BriaCell Therapeutics annual total long term liabilities?
The current annual total long term liabilities of BCTX is $1.10 M
What is the all time high annual total long term liabilities for BriaCell Therapeutics?
BriaCell Therapeutics all-time high annual total long term liabilities is $31.31 M
What is BriaCell Therapeutics annual total long term liabilities year-on-year change?
Over the past year, BCTX annual total long term liabilities has changed by -$28.04 M (-96.24%)
What is BriaCell Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of BCTX is $1.71 M
What is the all time high quarterly long term liabilities for BriaCell Therapeutics?
BriaCell Therapeutics all-time high quarterly total long term liabilities is $34.77 M
What is BriaCell Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, BCTX quarterly total long term liabilities has changed by -$3.97 M (-69.84%)